3/5/2014 2:00:00 AM
KineMed, Inc. announced today Marc Hellerstein, M.D., Ph.D., President, CSO, and Scientific Founder of KineMed, will lead the workshop titled “Flux Analysis” and give a presentation titled “Flux through target pathways and molecular networks as biomarkers for medical diagnostics and drug development.” Dr. Hellerstein’s presentation will take place today March 5th from 8:00-9:30 AM EST, at the Sanford Burnham Metabolic Origins of Disease Symposium taking place in Orlando, Florida.
2/27/2014 2:00:00 AM
EMERYVILLE, CA, February 27, 2014, – KineMed, Inc. announced today that Dr. Patrizia Fanara, Vice President of Neuroscience at KineMed, Inc., will give a presentation titled “Translational kinetic biomarkers to enable the development of HTT-lowering therapies” at the CHDI Foundation’s 9th Annual Huntington's Disease Therapeutics Conference, taking place February 27th in Palm Springs, California
1/13/2014 2:00:00 AM
KineMed, Inc. announced an agreement with EMD Serono to apply KineMed’s mass spectrometric Dynamic Proteomics and lipids platforms to the discovery of protein and lipid biomarkers for multiple sclerosis.
Marc Hellerstein, M.D., Ph.D., President and Chief Scientific Officer
talks about the power of Proteome Dynamics at the Personalized Medicine World Conference